vialauditThe Roundup
DSIP·US LEGAL STATUS·LAST CHECKED 12 OCT 2026

Is DSIP legal?

Not as a drug. DSIP has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. FDA's advisers voted against adding it to the pharmacy compounding list in July 2026, so pharmacies cannot compound it.

RESEARCH-LABELLED SALE
Unapproved drug
PHARMACY COMPOUNDING
No · PCAC voted against
PRESCRIPTION
No approved product
WADA 2026
Prohibited (S0)

DESCRIBES THE LAW · NOT LEGAL ADVICE · NO DOSING INFORMATION

Federal, compounding and sport status

CHECKED 12 OCT 2026

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
FDA interim category: Nominated but withdrawn (off Category 2, not eligible)
503A Bulks List: voted no
Not eligible. Removed from Category 2 on 15 Apr 2026, then the only one of seven peptides the PCAC voted against (as emideltide, 24 Jul 2026). Any stopgap built on the July votes would be unlikely to include it.
PCAC review history
  • Jul 24, 2026 · voted against · 7 no, 6 yes, 1 abstention (Reuters) · SOURCE ↗
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Unapproved; FDCA applies. July 2026 PCAC vote is the inflection point.
Personal possession: Not federally criminalized.

Sport-body status

WADA 2026
prohibited · class S0 · in and out of competition
Not named. S0 covers any pharmacological substance with no current approval by any government for human therapeutic use, and we found no such approval. WADA's 2027 List, in force from 1 Jan 2027, now names 'peptides' among the S0 examples; the status does not change.
USADA
NCAA
unknown

What we couldn’t verify

State rules

NONE FOUND

We found no state statute, board rule or enforcement action that names DSIP. The federal position above applies in all 50 states and DC.

What changed at the last check

5 CHANGES
DateFieldWasNowWhy
12 Oct 2026WADA 20272027 List not yet publishedprohibited (S0), unchangedWADA published the 2027 List on 21 Sep 2026. It adds 'peptides' to the S0 examples of substances with no approval for human therapeutic use. Status unchanged. source ↗
12 Oct 2026503A Bulks List statusunder pcac reviewvoted noNot eligible. Removed from Category 2 on 15 Apr 2026, then the only one of seven peptides the PCAC voted against (as emideltide, 24 Jul 2026). source ↗
12 Oct 2026FDA Category 2 (safety risk)under pcac reviewnot on listFDA's Category 2 page lists it under 'nominated but withdrawn', not in Category 2. source ↗
12 Oct 2026WADA 2026not prohibitedprohibited (S0)Not named. S0 covers any pharmacological substance with no current approval by any government for human therapeutic use, and we found no such approval. source ↗
12 Oct 2026PCAC reviewpending (vote scheduled)voted noPCAC vote on 2026-07-24: 7 no, 6 yes, 1 abstention (Reuters). source ↗

Questions

3 ANSWERS
Is DSIP legal in the US?

Not as a drug. DSIP has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. FDA's advisers voted against adding it to the pharmacy compounding list in July 2026, so pharmacies cannot compound it.

Can a pharmacy compound DSIP?

Not eligible. Removed from Category 2 on 15 Apr 2026, then the only one of seven peptides the PCAC voted against (as emideltide, 24 Jul 2026). Any stopgap built on the July votes would be unlikely to include it.

Is DSIP banned in sport?

Yes. It is prohibited at all times under WADA 2026 class S0. Not named. S0 covers any pharmacological substance with no current approval by any government for human therapeutic use, and we found no such approval. WADA's 2027 List, in force from 1 Jan 2027, now names 'peptides' among the S0 examples; the status does not change.

Sources

6 DOCUMENTS
  1. FDA approval record
  2. DEA controlled-substance schedules
  3. FDA 503A compounding position
  4. WADA 2026 Prohibited List
  5. Source for: WADA 2027
  6. Source for: FDA Category 2 (safety risk)
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH